FOLLOW US :
  • |
  • |

IPO

IPO

IPO Synopsis

Back
Sai Parenteral's Ltd
Registered Office: No.39 5th Flr Lavanya Arcade-,Jayabheri Enclave Gachibowli , Rangareddy - 500032 , Telangana , India.
Phone : +91 79979 91301   Fax:
Email :  cs@saiparenterals.com  
Website :  https://www.saiparenterals.com
Initial public offer of up to 10428288 equity shares of face value of Rs5 each ("Equity Shares") of Sai Parenteral's Limited ("Company" or "Issuer") for cash at a price of Rs392 per equity share (Including a Share Premium of Rs387 Per Equity Share) ("Offer Price") aggregating up to Rs408.79 Crore comprising a fresh issue of up to 7270408 equity shares of face value of Rs5 each aggregating up to Rs285 Crore by the company ("Fresh Issue") and an offer for sale of up to 3,157,880 equity shares of face value of Rs5 each aggregating up to Rs123.79 Crore ("Offered Shares") by investor selling shareholders (such sale, the "Offer For Sale", and together with the fresh issue, the"Offer"). The offer shall constitute [*]% of the post-offer paid up equity share capital of the company. Price Band: Rs372 to Rs392 per equity share of face value of Rs5 each. The floor price 74.40 times the face value of the equity shares and the cap price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of Rs5 each and in multiples of 38 equity shares of face value of Rs5 each thereafter.
Issue Money Payable On
Opens On Closes On Application Allotment
24-Mar-26 27-Mar-26 Rs 372.00-392.00 Rs 0.00-0.00
Minimum Application for shares in Nos :38  Further Multiples of :38
  (Rs Cr) Lead Managers to the Issue
Project Cost 0.00
Arihant Capital Markets Limited
Project Financed through Current Offer 402.47
Post Issue Equity Share Capital 23.67
Issue Price Rs 372.00
Projects
Capacity expansion and upgradation of manufacturing facilities Working capital requirements
Establishment of a new R&D Centre Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia)
Repayment / prepayment of certain outstanding borrowings General corporate purposes
Promoted By Listing At Registrar to the Issue
  Anil Kumar Karusala
  Vijitha Gorrepati
  Karusala Aruna
 BSE
 NSE
No Data Found.
Wednesday, March 25, 2026
Adani Ports1375.50(2.32)%
      
Asian Paints2270.20(2.41)%
      
Axis Bank1222.45(2.55)%
      
Bajaj Finance882.45(3.82)%
      
Bajaj Finserv1746.10(2.44)%
      
Bharat Electro..413.60(-0.27)%
      
Bharti Airtel1835.40(1.76)%
      
Eternal242.20(1.79)%
      
HCL Technologi..1382.35(0.66)%
      
HDFC Bank781.70(2.16)%
      
Hind. Unilever2135.90(2.46)%
      
ICICI Bank1259.80(0.65)%
      
Infosys1279.35(0.09)%
      
Interglobe Avi..4294.80(3.46)%
      
ITC295.75(1.56)%
      
Kotak Mah. Ban..371.30(1.13)%
      
Larsen & Toubr..3648.85(3.80)%
      
M & M3127.90(3.14)%
      
Maruti Suzuki12704.30(1.90)%
      
NTPC378.40(0.79)%
      
Power Grid Cor..295.10(-1.37)%
      
Reliance Indus..1412.55(0.08)%
      
SBI1060.55(2.89)%
      
Sun Pharma.Ind..1794.85(2.40)%
      
Tata Steel196.65(3.01)%
      
TCS2378.15(-0.86)%
      
Tech Mahindra1409.10(-1.66)%
      
Titan Company4038.40(3.50)%
      
Trent3478.10(3.33)%
      
UltraTech Cem.11204.45(4.12)%
      

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)